Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINE1 | P05121 | 6/20 | 0.88 |
| ▸ | ESR1 | P03372 | 2/20 | 0.66 |
| ▸ | TYR | P14679 | 3/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.65 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.62 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.62 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.62 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2791373 | 0.94 | SERPINE1 (1.00) | SERPINE1ESR1TYRL3MBTL1AKR1C4 | |
| SCHEMBL1885404 | 0.92 | SERPINE1 (0.81) | SERPINE1ESR1TYRL3MBTL1AKR1C4 | |
| Ethylene SCHEMBL16144959 | 0.90 | SERPINE1 (0.92) | SERPINE1ESR1TYRL3MBTL1AKR1C4 | |
| Ethylene SCHEMBL16144978 | 0.90 | SERPINE1 (0.92) | SERPINE1ESR1TYRL3MBTL1AKR1C4 | |
| Ethylene SCHEMBL16144967 | 0.90 | SERPINE1 (0.92) | SERPINE1ESR1TYRL3MBTL1AKR1C4 | |
| Ethylene SCHEMBL16144936 | 0.90 | SERPINE1 (0.92) | SERPINE1ESR1TYRL3MBTL1AKR1C4 | |
| Ethylene SCHEMBL16144942 | 0.90 | SERPINE1 (0.92) | SERPINE1ESR1TYRL3MBTL1AKR1C4 | |
| Ethylene SCHEMBL16145015 | 0.90 | SERPINE1 (0.92) | SERPINE1ESR1TYRL3MBTL1AKR1C4 | |
| Ethylene SCHEMBL16144939 | 0.90 | SERPINE1 (0.92) | SERPINE1ESR1TYRL3MBTL1AKR1C4 | |
| Ethylene SCHEMBL16144984 | 0.90 | SERPINE1 (0.92) | SERPINE1ESR1TYRL3MBTL1AKR1C4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250138031-A1 | IN VITRO MEASUREMENT OF THE LYSIS OF A FIBRIN CLOT | DIAGNOSTICA STAGO (FR) | 2025-05-01 | — | — | US | claimed |
| CN-118834553-A | Preparation method of flash rust inhibitor | 大连连昇新材料有限公司 | 2024-10-25 | — | — | CN | claimed |
| WO-2023041877-A1 | IN VITRO MEASUREMENT OF THE LYSIS OF A FIBRIN CLOT | DIAGNOSTICA STAGO (FR) | 2023-03-23 | — | — | WO | claimed |
| US-7208266-B2 | Endogenous coagulation activator compounds —use in exploring endogenous coagulation | SOCIETE DIAGNOSTICA-STAGO (FR) | 2007-04-24 | — | — | US | claimed |
| US-20030157582-A1 | Endogenous coagulation activator compounds - use in exploring endogenous coagulation | SOCIETE DIAGNOSTICA-STAGO (FR) | 2003-08-21 | — | — | US | claimed |
| EP-1280758-A1 | GALLIC ACID DERIVATIVES AND USE FOR EXPLORING ENDOGENETIC COAGULATION | SOCIETE DIAGNOSTICA-STAGO (FR) | 2003-02-05 | — | — | EP | claimed |
| WO-2002076921-A1 | GALLIC ACID DERIVATIVES AND USE FOR EXPLORING ENDOGENETIC COAGULATION | SOCIETE DIAGNOSTICA-STAGO (FR) | 2002-10-03 | — | — | WO | claimed |
| US-20250138031-A1 | IN VITRO MEASUREMENT OF THE LYSIS OF A FIBRIN CLOT | DIAGNOSTICA STAGO (FR) | 2025-05-01 | — | — | US | disclosed |
| CN-118834553-A | Preparation method of flash rust inhibitor | 大连连昇新材料有限公司 | 2024-10-25 | — | — | CN | disclosed |
| WO-2023041877-A1 | IN VITRO MEASUREMENT OF THE LYSIS OF A FIBRIN CLOT | DIAGNOSTICA STAGO (FR) | 2023-03-23 | — | — | WO | disclosed |
| US-20100298403-A1 | MODIFIED POLY(PROPYLENE-IMINE) DENDRIMERS AND THEIR USE AS TRANSFECTION AGENTS FOR AMIONIC BIOACTIVE FACTORS ( as amended | JANSSEN PHARMACEUTICA N.V. (BE) | 2010-11-25 | — | — | US | disclosed |
| EP-1904436-A1 | MODIFIED POLY(PROPYLENE-IMINE) DENDRIMERS AND THEIR USE AS TRANSFECTION AGENTS FOR ANIONIC BIOACTIVE FACTORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-04-02 | — | — | EP | disclosed |
| US-7208266-B2 | Endogenous coagulation activator compounds —use in exploring endogenous coagulation | SOCIETE DIAGNOSTICA-STAGO (FR) | 2007-04-24 | — | — | US | disclosed |
| WO-2007006700-A1 | MODIFIED POLY(PROPYLENE-IMINE) DENDRIMERS AND THEIR USE AS TRANSFECTION AGENTS FOR ANIONIC BIOACTIVE FACTORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-01-18 | — | — | WO | disclosed |
| US-20030157582-A1 | Endogenous coagulation activator compounds - use in exploring endogenous coagulation | SOCIETE DIAGNOSTICA-STAGO (FR) | 2003-08-21 | — | — | US | disclosed |
| EP-1280758-A1 | GALLIC ACID DERIVATIVES AND USE FOR EXPLORING ENDOGENETIC COAGULATION | SOCIETE DIAGNOSTICA-STAGO (FR) | 2003-02-05 | — | — | EP | disclosed |
| WO-2002076921-A1 | GALLIC ACID DERIVATIVES AND USE FOR EXPLORING ENDOGENETIC COAGULATION | SOCIETE DIAGNOSTICA-STAGO (FR) | 2002-10-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030157582-A1 | Endogenous coagulation activator compounds - use in exploring endogenous coagulation | TFPI, F2, F8 | SERPINE1 20/4885ESR1 1071/4885TYR 3148/4885 |
| US-20100298403-A1 | MODIFIED POLY(PROPYLENE-IMINE) DENDRIMERS AND THEIR USE AS TRANSFECTION AGENTS FOR AMIONIC BIOACTIVE FACTORS ( as amended | PAM, TIMM13, CYTH3 | SERPINE1 3454/4885ESR1 618/4885TYR 3193/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.